{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:47:58Z","timestamp":1771037278434,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Science Fund of china for Excellent Young Scholar","award":["31422049"],"award-info":[{"award-number":["31422049"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["31572289"],"award-info":[{"award-number":["31572289"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hubei Science Fund for Excellent Scholars","award":["2015CFA042"],"award-info":[{"award-number":["2015CFA042"]}]},{"name":"Fundamental Research Funds for the Central Universities in China","award":["2042014kf0205"],"award-info":[{"award-number":["2042014kf0205"]}]},{"name":"Fundamental Research Funds for the Central Universities in China","award":["2042015kf0255"],"award-info":[{"award-number":["2042015kf0255"]}]},{"name":"China Scholarship Council (CN)","award":["201308420306"],"award-info":[{"award-number":["201308420306"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00253-016-7395-x","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T20:04:39Z","timestamp":1457381079000},"page":"5069-5077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["K1K8: an Hp1404-derived antibacterial peptide"],"prefix":"10.1007","volume":"100","author":[{"given":"Zhongjie","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaomin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanxia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"issue":"3","key":"7395_CR1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3(3):238\u2013250. doi: 10.1038\/nrmicro1098","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"7395_CR2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.33.8.1318","volume":"33","author":"SP Cohen","year":"1989","unstructured":"Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB (1989) Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother 33(8):1318\u20131325","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"7395_CR3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMcp070747","volume":"357","author":"RS Daum","year":"2007","unstructured":"Daum RS (2007) Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 357(4):380\u2013390. doi: 10.1056\/NEJMcp070747","journal-title":"N Engl J Med"},{"issue":"8","key":"7395_CR4","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1128\/AAC.49.8.3208-3216.2005","volume":"49","author":"B Deslouches","year":"2005","unstructured":"Deslouches B, Islam K, Craigo JK, Paranjape SM, Montelaro RC, Mietzner TA (2005) Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob Agents Chemother 49(8):3208\u20133216. doi: 10.1128\/AAC.49.8.3208-3216.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"7395_CR5","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/320184","volume":"32","author":"DJ Diekema","year":"2001","unstructured":"Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, Grp SP (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997\u20131999. Clin Infect Dis 32:S114\u2013S132. doi: 10.1086\/320184","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7395_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd3591","volume":"11","author":"CD Fjell","year":"2012","unstructured":"Fjell CD, Hiss JA, Hancock RE, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11(1):37\u201351. doi: 10.1038\/nrd3591","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"7395_CR7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nbt.2572","volume":"31","author":"JL Fox","year":"2013","unstructured":"Fox JL (2013) Antimicrobial peptides stage a comeback. Nat Biotechnol 31(5):379\u2013382. doi: 10.1038\/nbt.2572","journal-title":"Nat Biotechnol"},{"issue":"4","key":"7395_CR8","first-page":"20","volume":"19","author":"C Graber","year":"2007","unstructured":"Graber C (2007) Skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Beta 19(4):20\u201326","journal-title":"Beta"},{"issue":"6","key":"7395_CR9","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","volume":"1","author":"NJ Greenfield","year":"2006","unstructured":"Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1(6):2876\u20132890. doi: 10.1038\/nprot.2006.202","journal-title":"Nat Protoc"},{"issue":"3","key":"7395_CR10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(01)00092-5","volume":"1","author":"RE Hancock","year":"2001","unstructured":"Hancock RE (2001) Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1(3):156\u2013164. doi: 10.1016\/S1473-3099(01)00092-5","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"7395_CR11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"REW Hancock","year":"2006","unstructured":"Hancock REW, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551\u20131557. doi: 10.1038\/Nbt1267","journal-title":"Nat Biotechnol"},{"issue":"8","key":"7395_CR12","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1128\/AAC.00124-10","volume":"54","author":"M Hartmann","year":"2010","unstructured":"Hartmann M, Berditsch M, Hawecker J, Ardakani MF, Gerthsen D, Ulrich AS (2010) Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrob Agents Chemother 54(8):3132\u20133142. doi: 10.1128\/AAC.00124-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"7395_CR13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13238-010-0004-3","volume":"1","author":"Y Huang","year":"2010","unstructured":"Huang Y, Huang J, Chen Y (2010) Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell 1(2):143\u2013152. doi: 10.1007\/s13238-010-0004-3","journal-title":"Protein Cell"},{"key":"7395_CR14","doi-asserted-by":"crossref","unstructured":"Jenssen H, Hamill P and Hancock REW (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19(3):491\u2013+. doi:10.1128\/Cmr.00056\u201305","DOI":"10.1128\/CMR.00056-05"},{"key":"7395_CR15","doi-asserted-by":"crossref","unstructured":"Jiang Z, Vasil AI, Gera L, Vasil ML and Hodges RS (2011) Rational design of alpha-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, \u2018specificity determinants,\u2019 total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Chem Biol Drug Des 77(4):225\u2013240. doi: 10.1111\/j.1747-0285.2011.01086.x","DOI":"10.1111\/j.1747-0285.2011.01086.x"},{"issue":"3","key":"7395_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.it.2008.12.003","volume":"30","author":"YP Lai","year":"2009","unstructured":"Lai YP, Gallo RL (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30(3):131\u2013141. doi: 10.1016\/J.It.2008.12.003","journal-title":"Trends Immunol"},{"issue":"5","key":"7395_CR17","volume":"9","author":"Z Li","year":"2014","unstructured":"Li Z, Xu X, Meng L, Zhang Q, Cao L, Li W, Wu Y, Cao Z (2014) Hp1404, a new antimicrobial peptide from the scorpion Heterometrus petersii. PLoS one 9(5):e97539. doi: 10.1371\/journal.pone.0097539","journal-title":"PLoS one"},{"issue":"8","key":"7395_CR18","first-page":"595","volume":"36","author":"SA Matuszczyk","year":"1983","unstructured":"Matuszczyk SA (1983) Antibiotic therapy in the light of the multiple drug resistance of bacteria. Czas Stomatol 36(8):595\u2013600","journal-title":"Czas Stomatol"},{"issue":"9","key":"7395_CR19","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/thorax.58.9.794","volume":"58","author":"TL Pitt","year":"2003","unstructured":"Pitt TL, Sparrow M, Warner M, Stefanidou M (2003) Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax 58(9):794\u2013796","journal-title":"Thorax"},{"issue":"1","key":"7395_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3949\/ccjm.79a.11044","volume":"79","author":"S Rajan","year":"2012","unstructured":"Rajan S (2012) Skin and soft-tissue infections: classifying and treating a spectrum. Cleve Clin J Med 79(1):57\u201366. doi: 10.3949\/ccjm.79a.11044","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"7395_CR21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1747-0285.2009.00847.x","volume":"74","author":"B Ranjbar","year":"2009","unstructured":"Ranjbar B, Gill P (2009) Circular dichroism techniques: biomolecular and nanostructural analyses\u2014a review. Chem Biol Drug Des 74(2):101\u2013120. doi: 10.1111\/j.1747-0285.2009.00847.x","journal-title":"Chem Biol Drug Des"},{"issue":"6","key":"7395_CR22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/AAC.26.6.797","volume":"26","author":"CC Sanders","year":"1984","unstructured":"Sanders CC, Sanders WE Jr, Goering RV, Werner V (1984) Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother 26(6):797\u2013801","journal-title":"Antimicrob Agents Chemother"},{"key":"7395_CR23","doi-asserted-by":"crossref","unstructured":"Sartelli M, Malangoni MA, May AK, Viale P, Kao LS, Catena F, Ansaloni L, Moore EE, Moore FA, Peitzman AB, Coimbra R, Leppaniemi A, Kluger Y, Biffl W, Koike K, Girardis M, Ordonez CA, Tavola M, Cainzos M, Di Saverio S, Fraga GP, Gerych I, Kelly MD, Taviloglu K, Wani I, Marwah S, Bala M, Ghnnam W, Shaikh N, Chiara O, Faro MP Jr, Pereira GA Jr, Gomes CA, Coccolini F, Trana C, Corbella D, Brambillasca P, Cui Y, Segovia Lohse HA, Khokha V, Kok KY, Hong SK, Yuan KC (2014) World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg 9(1):57. doi: 10.1186\/1749-7922-9-57","DOI":"10.1186\/1749-7922-9-57"},{"issue":"9","key":"7395_CR24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbamem.2006.02.021","volume":"1758","author":"H Sato","year":"2006","unstructured":"Sato H, Felix JB (2006) Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides. Biochimica Et Biophysica Acta-Biomembranes 1758(9):1245\u20131256. doi: 10.1016\/j.bbamem.2006.02.021","journal-title":"Biochimica Et Biophysica Acta-Biomembranes"},{"issue":"1\u20132","key":"7395_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0005-2736(99)00200-X","volume":"1462","author":"Y Shai","year":"1999","unstructured":"Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462(1\u20132):55\u201370","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"7395_CR26","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1172\/JCI38842","volume":"119","author":"NR Soman","year":"2009","unstructured":"Soman NR, Baldwin SL, Hu G, Marsh JN, Lanza GM, Heuser JE, Arbeit JM, Wickline SA, Schlesinger PH (2009) Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J Clin Invest 119(9):2830\u20132842. doi: 10.1172\/JCI38842","journal-title":"J Clin Invest"},{"issue":"8","key":"7395_CR27","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/AAC.00181-06","volume":"50","author":"H Steffen","year":"2006","unstructured":"Steffen H, Rieg S, Wiedemann I, Kalbacher H, Deeg M, Sahl HG, Peschel A, Gotz F, Garbe C, Schittek B (2006) Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother 50(8):2608\u20132620. doi: 10.1128\/AAC.00181-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"7395_CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jac\/44.1.33","volume":"44","author":"SB Tencza","year":"1999","unstructured":"Tencza SB, Creighton DJ, Yuan T, Vogel HJ, Montelaro RC, Mietzner TA (1999) Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerization. J Antimicrob Chemother 44(1):33\u201341","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"7395_CR29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00281-011-0300-x","volume":"34","author":"SY Tong","year":"2012","unstructured":"Tong SY, Chen LF, Fowler VG Jr (2012) Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Semin Immunopathol 34(2):185\u2013200. doi: 10.1007\/s00281-011-0300-x","journal-title":"Semin Immunopathol"},{"issue":"20","key":"7395_CR30","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.biomaterials.2008.04.023","volume":"29","author":"DF Williams","year":"2008","unstructured":"Williams DF (2008) On the mechanisms of biocompatibility. Biomaterials 29(20):2941\u20132953. doi: 10.1016\/j.biomaterials.2008.04.023","journal-title":"Biomaterials"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7395-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-016-7395-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7395-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T05:15:06Z","timestamp":1567660506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-016-7395-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["7395"],"URL":"https:\/\/doi.org\/10.1007\/s00253-016-7395-x","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]}}}